Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
mesna
Description:
Mesna is a thiol-containing pharmaceutical compound used to protect the urinary tract from toxic metabolites of certain chemotherapy drugs.
Related topics:
Chemotherapy-induced organ toxicity mitigation (18%),
Sarcoma Diagnosis and Treatment (12%)
Wikidata ID:
wiki/Q424997
OpenAlex ID:
keywords/mesna
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014
·
Ian Judson
, Jaap Verweij
, et al.
·
The Lancet Oncology
·
1,218
PDF
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
2001
·
Sergio Frustaci
, Franco Gherlinzoni
, et al.
·
Journal of Clinical Oncology
·
721
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
2008
·
Martee L. Hensley
, Karen L. Hagerty
, et al.
·
Journal of Clinical Oncology
·
540
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
1993
·
K Antman
, J Crowley
, et al.
·
Journal of Clinical Oncology
·
479
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
2000
·
C. Peter
, D. Hongwan
, et al.
·
European Journal of Clinical Pharmacology
·
376
American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants
1999
·
Martee L. Hensley
, LynnM. Schuchter
, et al.
·
Journal of Clinical Oncology
·
336
Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.
1995
·
A Bedi
, C B Miller
, et al.
·
Journal of Clinical Oncology
·
319
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
1987
·
J S Miser
, T J Kinsella
, et al.
·
Journal of Clinical Oncology
·
316
Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas
2003
·
Thomas F DeLaney
, Ira J Spiro
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
309
Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation
2007
·
A. Korkmaz
, T. Topal
, et al.
·
Cell Biology and Toxicology
·
289
Salvage Therapy in Recurrent Germ Cell Cancer: Ifosfamide and Cisplatin plus Either Vinblastine or Etoposide
1988
·
Patrick J. Loehrer
, Richard Lauer
, et al.
·
Annals of Internal Medicine
·
278
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
1989
·
A Elias
, L Ryan
, et al.
·
Journal of Clinical Oncology
·
275
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide
1994
·
Gerald Rosen
, Charles Forscher
, et al.
·
Cancer
·
268
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆
2007
·
A WOLFSON
, M BRADY
, et al.
·
Gynecologic Oncology
·
261
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
1997
·
S R Patel
, S Vadhan-Raj
, et al.
·
Journal of Clinical Oncology
·
258
Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
1987
·
Vivien H.C. Bramwell
, H.T. Mouridsen
, et al.
·
European Journal of Cancer and Clinical Oncology
·
243
Ifosfamide, mesna, and nephrotoxicity in children.
1993
·
R Skinner
, I M Sharkey
, et al.
·
Journal of Clinical Oncology
·
241
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
1989
·
K H Antman
, L Ryan
, et al.
·
Journal of Clinical Oncology
·
237
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
2004
·
S.R. Grobmyer
, R.G. Maki
, et al.
·
Annals of Oncology
·
223
Hemorrhagic Cystitis: A Review
1990
·
Catherine R. de Vries
, Fuad S. Freiha
·
The Journal of Urology
·
216
Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study
1996
·
Gregory Sutton
, John A. Blessing
, et al.
·
Gynecologic Oncology
·
213
Ifosfamide/Mesna: A Review of its Antineoplastic Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Cancer
1991
·
Kerry L. Dechant
, Rex N. Brogden
, et al.
·
Drugs
·
188
Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.
1997
·
R S Witte
, P Elson
, et al.
·
Journal of Clinical Oncology
·
186
Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
1979
·
N Brock
, J Stekar
, et al.
·
PubMed
·
186
Ifosfamide in the Adjuvant Therapy of Soft Tissue Sarcomas
2003
·
S. Frustaci
, A. De Paoli
, et al.
·
Oncology
·
184
Show more works
View as search
Works count:
1,848
Citation count:
34,150
Year
Topic
Type